Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

ARCADIAN

ARCADIAN: Atovaquone with Radical ChemorADIotherapy in locally Advanced NSCLC

CEDAR

Chemoradiation with Enadenotucirev as a radiosensitiser in locally Advanced Rectal cancer

CHARIOT

M6620 plus standard treatment in oesophageal and other cancer

CYTOFLOC

Cytosponge™ for post‐chemoradiation surveillance of oesophageal cancer

FRONTIER

Fluciclovine (18F) imaging of breast cancer

IMAGO

A single arm exploratory study examining the feasibility of imaging glioblastoma pH using CEST MRI

IPI-GLIO

Ipilimumab with Temozolomide versus Temozolomide alone after surgery and chemoradiotherapy in patients with recently diagnosed glioblastoma

LUD2015-005

Anti-PD-L1 in Combination with Chemo(radio)therapy for Oesophageal Cancer

NEOPANC-01

Pre-operative, Window-of-opportunity Study to Assess Gene Expression in Patients With Resectable, Locally Advanced, or Metastatic Pancreatic Cancer

NuTide:301

Safety, pharmacokinetics and clinical activity of NUC-3373, a nucleotide analogue, in participants with advanced solid tumours.

OCTOVA

Paclitaxel, olaparib and cediranib in platinum-resistant ovarian cancer.

OxPLoreD

Oxford Pre-Cancerous Lymphoproliferative Disorders: Analysis and Interception study

SCALOP-2

Systemic therapy and Chemoradiation in Advanced Localised Pancreatic cancer–2